Since the pandemic started, we've seen our reagents used to make important discoveries and observations about the virus. Back in 2021, scientists worked with our Human Small Intestine Endothelial Cells (cat. HEC15) to compare the plasma of healthy patients to those with COVID-19 (learn more). Then, in 2022, researchers infected our Primary Human Neurons (cat. HNC001) with COVID-19 in a publication. They observed the creation of an Alzheimer's-like neuropathology in the formerly healthy neurons (read it here).
Image: Human brain microvascular pericytes stained with VWF/Factor VIII.
Now, preliminary research has just been released looking at the interaction between COVID-19 and HIV. In the citation, the investigators from UNMC and the Karolinska Institutet employed our Human Brain Astrocytes (cat. HMP202) and Human Brain Microvascular Pericytes (cat. HMP104).
In the study, the researchers created various scenarios with both cell types, where samples were infected with HIV and SARS-CoV-2 alone or together. Based on the gene analysis of the cells, the infection with the viruses enriched many gene pathways leading to neurological disorders. We encourage you to check out the full publication here.
Image: Human brain strocytes stained with GFAP.
Neuromics has a number of human primary cells with proven results. You can explore all citations using our human cells here. The publications span a variety of applications, including cancer, neurodegenerative disease, diabetes, hypertension, and so much more research.
Our human cell offerings are broad and continuing to expand. We have tons of primary CNS cells, cancer associated fibroblasts (CAFs), and endothelial cells, just to name a few. Find all our cell options here.
